1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biopsy Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of cancer and gastrointestinal diseases
5.1.1.2. Rise in adoption of minimally-invasive techniques
5.1.1.3. Increasing awareness of the importance of early detection and screening of diseases
5.1.2. Restraints
5.1.2.1. High cost associated with the production of biopsy devices
5.1.3. Opportunities
5.1.3.1. Continuous technological advancements in biopsy devices
5.1.3.2. Growing inclination towards liquid biopsy devices
5.1.4. Challenges
5.1.4.1. Problems associated with stringent regulations by health authorities
5.2. Market Segmentation Analysis
5.2.1. Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
5.2.2. Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
5.2.3. Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
5.2.4. End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
5.3. Market Trend Analysis
5.3.1. Growing research activities in developing novel biopsy devices coupled with robust presence of major companies in the Americas region
5.3.2. Increasing product approvals from regional regulatory bodies coupled with growing research and development activities to expand the application of biopsy devices in the APAC region
5.3.3. Advanced healthcare facilities and cancer detection and prevention program in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biopsy Devices Market, by Product
6.1. Introduction
6.2. Biopsy Forceps
6.3. Localization Wires
6.4. Needle-Based Biopsy Instruments
6.5.1. Aspiration Needles
6.5.2. Core Biopsy Devices
6.5.3. Vacuum-Assisted Biopsy Devices
6.5. Procedure Trays
7. Biopsy Devices Market, by Technique
7.1. Introduction
7.2. Image Guided Biopsy
7.3.1. MRI-Guided Biopsy
7.3.2. Stereotactic-Guided Biopsy
7.3.3. Ultrasound-Guided Biopsy
7.3. Non-Image Guided Biopsy
8. Biopsy Devices Market, by Application
8.1. Introduction
8.2. Bone Marrow Biopsy
8.3. Breast Biopsy
8.4. Kidney Biopsy
8.5. Lung Biopsy
8.6. Prostate Biopsy
9. Biopsy Devices Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Diagnostic & Imaging Centers
9.4. Hospitals
10. Americas Biopsy Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biopsy Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biopsy Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Merit Medical Acquires AngioDynamics’ Catheter Portfolio and Biopsy System
13.3.1.2. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Terumo India Partners with Argon Medical to Expand Portfolio
13.3.3. New Product Launch & Enhancement
13.3.3.1. Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
13.3.3.2. Argon’s SuperCore Advantage Biopsy Instrument Launched in United States
13.3.3.3. Innovia Medical Launches the Oral Rotating Biopsy Punch at BACO International 2023
13.3.3.4. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
13.3.4. Award, Recognition, & Expansion
13.3.4.1. LUMINELLE Announces China National Intellectual Property Administration’s Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
13.3.4.2. Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
13.3.4.3. Guardant360 CDx Gets FDA Approval as Companion Diagnostic for ORSERDU
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Advin Health Care
14.1.2. Argon Medical Devices, Inc.
14.1.3. Axlab Limited
14.1.4. B. Braun SE
14.1.5. Becton, Dickinson and Company
14.1.6. Boston Scientific Corporation
14.1.7. Cardinal Health, Inc.
14.1.8. CONMED Corporation
14.1.9. Cook Group Incorporated
14.1.10. Danaher Corporation
14.1.11. F. Hoffmann-La Roche Ltd.
14.1.12. Ferrosan Medical Devices A/S
14.1.13. Fujifilm Holdings Corporation
14.1.14. Guardant Health, Inc.
14.1.15. Hologic, Inc.
14.1.16. Innovia Medical
14.1.17. INRAD, Inc.
14.1.18. Integra LifeSciences Holdings Corporation
14.1.19. IZI Medical Products, LLC by Halma PLC
14.1.20. JEB Technologies Limited
14.1.21. Limaca-Medical
14.1.22. MediTech Devices Pvt Ltd.
14.1.23. Medtronic PLC
14.1.24. Merit Medical Systems, Inc.
14.1.25. Mermaid Medical
14.1.26. Olympus Corporation
14.1.27. PAJUNK GmbH Medizintechnologie
14.1.28. Remington Medical
14.1.29. Spectra Medical Devices, LLC
14.1.30. Stryker Corporation
14.1.31. Suretech Medical Inc.
14.1.32. Trajan Scientific and Medical Pty Ltd.
14.1.33. TransMed7, LLC
14.1.34. TSK Laboratory
14.1.35. UVision360
14.1.36. Volkmann MedizinTechnik GmbH
14.1.37. weLLgo Medical Products GmbH
14.1.38. Zamar Care
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
